Implant Care

Do Breast Implants Need Replacing Every 10 Years?

UNE Plastic Surgery · Dr. Kim Uigeon, board-certified plastic surgeon · Published 2026-09-21 · Updated 2026-09-21

1. Where the “10-year” idea comes from

It is a misunderstanding built from three separate things.

First, the FDA sentence “not a lifetime device.” In 2020 the FDA recommended that all implant manufacturers add a boxed warning stating “Breast implants are not considered lifetime devices.”^[1] That means they are not permanent and need monitoring — it does not name a number of years. As the message spread, “not lifetime” quietly became “so, how long — about 10?”

Second, the manufacturer warranty. Some manufacturers offer a 10-year limited warranty that covers part of the replacement cost if the implant ruptures within that period. Terms differ by brand and registration date and change over time. That is a commercial policy, not a medical lifespan — a 5-year car warranty does not mean you replace the car every 5 years.

Third, an FDA statistic quoted only halfway. The patient decision checklist notes that “up to 20% of augmentation patients will have their implants removed within 8 to 10 years.” But the original text adds, right after, “however, my implants may last for a shorter or longer time.”^[1] That second half is rarely quoted. Read the other way, it also means about 80% do not have them removed in that window. It is a statistic about the possibility of revision surgery, not a replacement interval.

Two more ideas were added on top: that the “average lifespan is 10–15 years” (an average is only an average — some need surgery at 5 years, others go 20 without a problem), and that a periodic screening recommendation (“get checked at 5–6 years”) was retold as a replacement recommendation. Screening confirms the state of the implant; it does not book a replacement.

2. What the FDA actually recommends

The six points the FDA asked to appear in the boxed warning are these:^[1]

None of the six mentions a replacement interval. Instead the FDA recommends a screening schedule. For silicone gel implants, get a first ultrasound or MRI at 5–6 years after surgery, then repeat every 2–3 years.^[2] Saline implants have no routine imaging recommendation, because a rupture changes the shape and is visible. The key idea: whether to replace is decided by imaging findings, not by time. If a rupture or complication is confirmed, replace; if it is normal, leave it.

3. What implants actually looked like at 10 years

One study followed “10 years” directly. In the clinical trial behind the U.S. FDA approval, 715 patients were seen every year for 10 years, and one third had MRI at years 1, 3, 5, 7 and 9 to check for rupture (Spear & Murphy, Plastic and Reconstructive Surgery, 2014).^[3]

• At 10 years, 81.8% of augmentation patients still had their original implants.
• The 10-year cumulative capsular contracture rate in augmentation was 18.9%; submuscular placement (15.7%) was lower than subglandular (26.3%).
• In the MRI subgroup, rupture was 13.0% by patient and 7.7% by implant.
• 94.2% of augmentation patients reported being satisfied.

Read these numbers both ways. Eight in ten did not replace their implants at 10 years, so “they go at 10” is not true. At the same time, roughly one in ten had a rupture they did not know about, and capsular contracture accumulated with time, so “you can ignore them after 10 years” is not true either. The answer is not replacement — it is checking. (These implants were an early-2000s generation; today's more cohesive gels report lower rupture rates, so the same follow-up now would likely show better numbers.)

4. The real issue: silent rupture

This concept matters far more than the number 10. A silicone implant can rupture without any outward sign — called silent rupture — because the cohesive gel holds its shape even when the shell tears. The breast looks the same, feels similar and does not hurt. This is exactly why the FDA recommends imaging even for people without symptoms.

How common is it? In a study of 100 women who requested removal of silicone gel implants, 57% of the 186 explanted implants were already ruptured or leaking, after a mean of about 12 years in place (Peters et al., Annals of Plastic Surgery, 1997).^[6] These were patients who suspected a problem, so their rupture rate is higher than in the general population — but it shows that unnoticed rupture is more common than people assume. So 10 years is a point to inspect, not a point to replace.

With modern cohesive gels, a torn shell usually stays within the capsule rather than spreading quickly as older liquid silicone did. That does not mean it can be ignored: over time the gel can migrate outside the capsule or lead to inflammation and capsular contracture, and the surgery then becomes larger. A planned operation is not the same as an operation after the problem has grown.

Ultrasound or MRI — which do you need?

Both detect rupture, but they differ. Ultrasound is accessible and low-cost, useful as a first screen, though the result depends on the operator's skill. MRI is the most accurate test for silent rupture. Its accuracy has been checked against surgery: in a study where 118 implants judged on MRI were actually explanted, accuracy was 92% (sensitivity 89%, specificity 97%) (Hölmich et al., European Journal of Radiology, 2005).^[4]

By contrast, physical examination detects rupture poorly. When the same group examined 109 implants and compared with MRI, the sensitivity of examination was 30%; 43 of 85 implants judged intact on examination were ruptured on MRI (Hölmich et al., Annals of Plastic Surgery, 2005).^[5] That is why “the doctor felt it and said it was fine” is not reassurance on its own. Ultrasound is usually first; if it is unclear or rupture is suspected, MRI follows; with clear symptoms, MRI is used from the start.

5. When to discuss replacement

Regardless of how many years it has been, do not wait for the next scheduled check if any of these appear:

Mild capsular contracture can be observed; replacement or capsule correction is considered when pain or shape change is clear.

6. Replacement versus revision

Many people treat these as the same; the difficulty is quite different. A simple exchange removes the old implant and places a new one; if the existing pocket is still usable, it is relatively straightforward. A revision adds correction — trimming the capsule, repositioning a displaced implant, rebuilding the inframammary fold, or lifting sagging at the same time — and the operating time and recovery change accordingly.

So it helps to arrive at consultation clear about whether you want to change only the implant, or also improve the shape. One more point: the breast shape can change while the implant is perfectly fine — from weight change, pregnancy and breastfeeding, or skin-elasticity changes with age. That is a tissue-change issue, not an implant-lifespan issue, and it is approached differently.

7. What the FDA really wanted to say

The most important part of the guidance is not the warning box — it is the patient decision checklist. The FDA recommended a document that patient and surgeon review and sign together before surgery, covering when implants should not be used, the risks of implant surgery, why the surgeon's training and experience matter, the risks of BIA-ALCL and systemic symptoms, and whether there are alternatives.^[1]

In other words, the FDA's message was not “replace every N years” but “make sure patients are fully informed and decide for themselves.” This matters because, in the 100-patient study above, 56% of those who had their implants removed said they had not been adequately informed at their first surgery.^[6] That is a bigger problem than the number 10.

8. Bottom line

1. “Replace at 10 years” is a misunderstanding, not a rule. It was built from the FDA's “not a lifetime device” sentence, the manufacturer's 10-year warranty, and the “up to 20% within 8–10 years” statistic quoted halfway.
2. What the FDA actually recommends is a screening schedule. For silicone, a first check at 5–6 years, then every 2–3 years. Replacement is decided by imaging.
3. At 10-year follow-up, 81.8% still had their original implants — while 13% had rupture on MRI. A matter to check, not to replace by default.
4. Ten years is an inspection point, not a replacement date. Physical examination catches only 30% of ruptures; MRI catches 92%. Imaging is needed even without symptoms.

Change the question: not “how many years, so should I replace?” but “what is the current state of my implant?” The answer is in the imaging, not the calendar.

References

1. U.S. Food and Drug Administration. Breast Implants — Certain Labeling Recommendations to Improve Patient Communication. Guidance for Industry and FDA Staff. 2020. (Six boxed-warning points; patient decision checklist.)
2. U.S. Food and Drug Administration. Risks and Complications of Breast Implants. (Silicone gel: ultrasound or MRI at 5–6 years, then every 2–3 years.)
3. Spear SL, Murphy DK. Natrelle round silicone breast implants: Core Study results at 10 years. Plast Reconstr Surg. 2014;133(6):1354–1361. (715 patients over 10 years; 81.8% retained original implants; MRI-subgroup rupture 13.0%.)
4. Hölmich LR, Vejborg I, Conrad C, Sletting S, McLaughlin JK. The diagnosis of breast implant rupture: MRI findings compared with findings at explantation. Eur J Radiol. 2005;53(2):213–225. (118 implants; MRI accuracy 92%.)
5. Hölmich LR, Fryzek JP, Kjøller K, et al. The diagnosis of silicone breast-implant rupture: clinical findings compared with findings at magnetic resonance imaging. Ann Plast Surg. 2005;54(6):583–589. (109 implants; examination sensitivity 30%.)
6. Peters W, Smith D, Fornasier V, Lugowski S, Ibanez D. An outcome analysis of 100 women after explantation of silicone gel breast implants. Ann Plast Surg. 1997;39(1):9–19. (186 explanted; 57% ruptured or leaking; a self-selected group requesting removal.)